Rei Tsang Shiao

Array ( [id] => 9254736 [patent_doc_number] => 08618154 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-12-31 [patent_title] => 'LXR modulators' [patent_app_type] => utility [patent_app_number] => 13/319937 [patent_app_country] => US [patent_app_date] => 2010-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25047 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13319937 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6054708 [patent_doc_number] => 20110111068 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Inhibitors of cognitive decline' [patent_app_type] => utility [patent_app_number] => 12/800500 [patent_app_country] => US [patent_app_date] => 2010-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7869 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20110111068.pdf [firstpage_image] =>[orig_patent_app_number] => 12800500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8543668 [patent_doc_number] => 08318960 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-27 [patent_title] => 'Diarylphosphine- and dialkylphosphine-containing compounds, processes of preparing same and uses thereof as tridentate ligands' [patent_app_type] => utility [patent_app_number] => 12/779093 [patent_app_country] => US [patent_app_date] => 2010-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 13 [patent_no_of_words] => 29793 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12779093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483925 [patent_doc_number] => 20120283332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'TRANSDERMAL DELIVERY OF METFORMIN' [patent_app_type] => utility [patent_app_number] => 13/504799 [patent_app_country] => US [patent_app_date] => 2010-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5134 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504799 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10191777 [patent_doc_number] => 09220669 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-29 [patent_title] => 'Resveratrol ferulate compounds, compositions containing the compounds, and methods of using the same' [patent_app_type] => utility [patent_app_number] => 12/775676 [patent_app_country] => US [patent_app_date] => 2010-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17972 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12775676 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166794 [patent_doc_number] => 08592471 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'Substituted phenylureas and phenylamides as vanilloid receptor ligands' [patent_app_type] => utility [patent_app_number] => 12/775235 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 56703 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12775235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8560251 [patent_doc_number] => 08334315 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-18 [patent_title] => 'Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands' [patent_app_type] => utility [patent_app_number] => 12/775155 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68112 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12775155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8435571 [patent_doc_number] => 08283340 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-09 [patent_title] => 'Treatment or prophylaxis of proliferative conditions' [patent_app_type] => utility [patent_app_number] => 12/771923 [patent_app_country] => US [patent_app_date] => 2010-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 39621 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12771923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6055727 [patent_doc_number] => 20110112087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-12 [patent_title] => 'Thia-triaza-cyclopentazulenes' [patent_app_type] => utility [patent_app_number] => 12/763537 [patent_app_country] => US [patent_app_date] => 2010-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21654 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20110112087.pdf [firstpage_image] =>[orig_patent_app_number] => 12763537 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8469876 [patent_doc_number] => 08299054 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-30 [patent_title] => 'Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors' [patent_app_type] => utility [patent_app_number] => 12/759867 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49084 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12759867 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262023 [patent_doc_number] => 20100297035 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'Thiazole Amides, Imidazole Amides and Related Analogues' [patent_app_type] => utility [patent_app_number] => 12/758116 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26907 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 47 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297035.pdf [firstpage_image] =>[orig_patent_app_number] => 12758116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8340378 [patent_doc_number] => 08242301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-14 [patent_title] => 'Mixed fluoroalkyl-alkyl surfactants' [patent_app_type] => utility [patent_app_number] => 12/758280 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12395 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12758280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8555241 [patent_doc_number] => 08329713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-12-11 [patent_title] => 'Fused ring heterocycles as potassium channel modulators' [patent_app_type] => utility [patent_app_number] => 12/757909 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 16184 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12757909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6276281 [patent_doc_number] => 20100256202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => '5,6-DIARYL PYRIDINES SUBSTITUTED IN THE 2- AND 3-POSITION, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/755883 [patent_app_country] => US [patent_app_date] => 2010-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19525 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20100256202.pdf [firstpage_image] =>[orig_patent_app_number] => 12755883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8527858 [patent_doc_number] => 08304428 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-11-06 [patent_title] => 'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners' [patent_app_type] => utility [patent_app_number] => 12/753319 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14138 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12753319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6451167 [patent_doc_number] => 20100280282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'PHOSPHATIDYL OLIGOGLYCEROLS' [patent_app_type] => utility [patent_app_number] => 12/751051 [patent_app_country] => US [patent_app_date] => 2010-03-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13653 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280282.pdf [firstpage_image] =>[orig_patent_app_number] => 12751051 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9524227 [patent_doc_number] => 08748493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-06-10 [patent_title] => 'Inhibitors of cathepsin S for prevention or treatment of obesity-associated disorders' [patent_app_type] => utility [patent_app_number] => 13/202339 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 13527 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6546415 [patent_doc_number] => 20100222306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Class of Gamma Delta T Cells Activators and Use Thereof' [patent_app_type] => utility [patent_app_number] => 12/728303 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18691 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222306.pdf [firstpage_image] =>[orig_patent_app_number] => 12728303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363768 [patent_doc_number] => 08252836 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 12/728925 [patent_app_country] => US [patent_app_date] => 2010-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 5197 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12728925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467104 [patent_doc_number] => 20100190822 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'Pharmaceutical Compositions As Inhibitors of Dipeptidyl Peptidase-IV (DPP-IV)' [patent_app_type] => utility [patent_app_number] => 12/727558 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52197 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190822.pdf [firstpage_image] =>[orig_patent_app_number] => 12727558 [rel_patent_id] =>[rel_patent_doc_number] =>)